US › Healthcare

Aspire BioPharma, Inc. (ASBP)

US · Healthcare · Biotechnology

$7.04-2.63%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$28,353

Net profit

$-3.2M

Profit YoY

+79.8%

EPS

$-20.57

Net margin

-11,367.0%

Key statistics

Market cap

$8.4M

Forward P/E

0.0

P/B

2.18

Book value

$23.10

EPS (TTM)

$-7.08

52-week high

$1,050.36

52-week low

$3.31

50-day MA

$6.11

200-day MA

$4.39

Beta

0.15

Shareholding

Insiders

5.91%

Institutions

0.99%

Largest institutional holders

Fund	Stake
UBS Group AG	0.49%
Morgan Stanley - Brokerage Accounts	0.20%
Geode Capital Management, LLC	0.11%
Crewe Advisors LLC	0.05%
Vanguard Capital Management, LLC	0.02%
Vanguard Fiduciary Trust Co	0.01%
Tower Research Capital LLC	0.01%
Citigroup Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aspire BioPharma, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.